Literature DB >> 30470911

Clinical characteristics and prognosis of cardiac tamponade patients: 5‑year experience at a tertiary center.

E Kızıltunç1, S Ünlü2, I E Yakıcı3, H Kundi3,4, A Korkmaz3, M Çetin3, E Örnek3.   

Abstract

BACKGROUND: Cardiac tamponade (CT) is characterized by compression of the cardiac chambers due to pericardial fluid accumulation. The etiology and prognosis may vary in different regions, and thus patient series from various regions can be useful for exploring the etiological and prognostic disparities. The aim of this study was to determine the clinical characteristics of patients with imminent CT, to evaluate the diagnostic performance of biochemical, microbiologic, and pathologic laboratory analysis, and to ascertain the prognosis of CT patients.
METHODS: We enrolled all patients with imminent CT who underwent percutaneous pericardiocentesis between July 2012 and December 2017 in this retrospective study. The patients were classified into three etiology groups: (a) malignancy (MRCT); (b) iatrogenic/mechanical complication of myocardial infarction (IMCT); and (c) other causes (OCT). Clinical information, laboratory findings, and survival data were recorded.
RESULTS: In total, 186 pericardiocentesis procedures were performed on 153 consecutive patients with CT. The median follow-up was 137 days (range: 1-1937). The MRCT group had the highest mortality rate (79%) in 12 months, while the OCT group had the lowest rate (27%). We determined that increased age, higher serum urea levels, and malignancy-related CT were independent predictors of mortality. The mortality rates of the MRCT and IMCT groups were similar, with both of them being significantly higher than the rate of the OCT group. In all, 15 patients were diagnosed with a new malignancy via pericardial fluid cytology.
CONCLUSION: Patients in the MRCT and IMCT groups had a poor prognosis. The presence of malignancy was found to be the most powerful predictor of mortality in CT patients.

Entities:  

Keywords:  Etiology; Pericardial effusion; Pericardial tamponade; Pericardiocentesis; Prognosis

Year:  2018        PMID: 30470911     DOI: 10.1007/s00059-018-4769-0

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  1 in total

1.  Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma.

Authors:  Ashley Way; Savas Ozdemir; Barbara Berges; Nataliya Getman; Xiaoying Liang; Nancy P Mendenhall; Graham Collins; David Cutter; Raymond B Mailhot Vega
Journal:  Int J Part Ther       Date:  2021-10-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.